Back

The impact of low-dose anticoagulation therapy on peripheral artery disease: insights from the VOYAGER trial

Cardiovascular Research

26 September 2020
Organised by: Logo
Read full article
ESC Journals

Contributors

Eri Fukaya
Eri Fukaya

Author

Nicholas J Leeper
Nicholas J Leeper

Author

Stanford University School of Medicine Palo Alto , United States of America

You may be interested in
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients
19 July 2023
thumbnail
Congress Presentation
The impact of statin treatment intensity after endovascular revascularization for lower extremity peripheral artery disease
27 August 2022
thumbnail
Congress Presentation
Low-dose anticoagulation for peripheral deep vein thrombosis of the lower extremities in cancer patients
27 August 2022
thumbnail
Congress Presentation
Peripheral artery disease, antithrombotic treatment and outcomes in European and Asian patients with atrial aibrillation: a report from 2 prospective observational registries
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources